efficacy and safety of therapeutics in immuno-modulatory induced cytokine release syndrome
Published 2 years ago • 562 plays • Length 55:15Download video MP4
Download video MP3
Similar videos
-
56:58
translatable efficacy & safety testing of mab, bispecific, & car t therapies
-
13:33
micetech talk, episode 32: let's talk cytokine release syndrome (16-mar-2021)
-
21:31
episode 37: let's talk how to test if your drug induces a cytokine storm (25may2021)
-
51:02
webinar: in vivo preclinical efficacy & safety of car-t, -nk, and -myeloid based therapies
-
57:52
webinar: human immune system engrafted platforms for more translatable preclinical research
-
2:01
managing cytokine release syndrome during car-t cell therapy
-
11:42
what is cytokine release syndrome?
-
1:14
what is cytokine release syndrome or crs?
-
16:40
jax tech talk #48: developing immunotherapies with hu-nsg-mhc i/ii dko mice (11jan2022)
-
37:48
utilization of an in vivo pbmc humanized mouse model for determining bispecific antibody related...
-
15:48
cytokine storm - pathophysiology mechanism | cytokine release syndrome
-
4:09:16
cytokine release syndrome in children - virtual cme - day 3
-
10:29
cytokine storm & old age -p2 | cytokine release syndrome | covid-19
-
16:26
jax tech talk # 51: let’s talk accelerating research with jax’s gvhd platform (1 mar 2022)
-
36:08
antibody drug development summit autumn 2021 - brian soper, ph.d.
-
12:37
jax tech talk, episode 43: let’s talk assessing efficacy of gvhd therapeutics (14sep2021)
-
7:30
realizing the promise of genomic medicine: introducing the jackson laboratory
-
10:45
cytokines
-
1:08
partow kebriaei on monitoring patients for cytokine release syndrome